All lobbying filings

MEDSECUREAN.COM

Lobbying for LUPIN PHARMACEUTICALS · Lupin Pharmaceuticals is a generic manufacturing company

Filing Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 13, 2026

Income

$54,000.00

What the client paid this registrant for the period.

Client based in

Florida

Official filing document

Government bodies contacted 6

Commerce, Dept of (DOC)
Health & Human Services, Dept of (HHS)
SENATE
State, Dept of (DOS)
U.S. Trade Representative (USTR)
White House Office

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Policies that promote the long-term sustainability of the U.S. generic pharmaceutical industry and preserve reliable patient access to affordable medicines.

Trade (domestic/foreign)

Tarrifs - generic medicine

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.